Bolt Biotherapeutics Inc
General ticker "BOLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $21.8M
Bolt Biotherapeutics Inc does not follow the US Stock Market performance with the rate: -39.1%.
Estimated limits based on current volatility of 3.7%: low 0.48$, high 0.52$
Factors to consider:
- Current price 27.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.71$, 1.91$]
- 2024-12-30 to 2025-12-30 estimated range: [0.98$, 2.43$]
Financial Metrics affecting the BOLT estimates:
- Negative: Non-GAAP EPS, $ of -1.83 <= 0.10
- Negative: Operating profit margin, % of -90.63 <= 1.03
- Negative: Operating cash flow per share per price, % of -65.74 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
Short-term BOLT quotes
Long-term BOLT plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1.26MM | $5.73MM | $7.88MM |
Operating Expenses | $94.05MM | $96.05MM | $84.07MM |
Operating Income | $-92.79MM | $-90.32MM | $-76.20MM |
Non-Operating Income | $-5.80MM | $2.22MM | $7.00MM |
R&D Expense | $75.66MM | $73.12MM | $61.54MM |
Income(Loss) | $-98.59MM | $-88.10MM | $-69.20MM |
Profit(Loss) | $-98.59MM | $-88.10MM | $-69.20MM |
Stockholders Equity | $250.12MM | $171.51MM | $112.74MM |
Inventory | $0.20MM | $0.80MM | $0.00MM |
Assets | $307.72MM | $227.81MM | $159.78MM |
Operating Cash Flow | $-57.07MM | $-76.50MM | $-69.53MM |
Capital expenditure | $2.34MM | $1.95MM | $0.21MM |
Investing Cash Flow | $-232.20MM | $57.86MM | $71.04MM |
Financing Cash Flow | $311.11MM | $0.50MM | $0.25MM |
Earnings Per Share* | $-2.79 | $-2.30 | $-1.83 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.